The ILUMYA Pen offers eligible patients a safe and effective treatment option that supports ease of use and may help reduce clinical visits through self-administration MUMBAI, India and BRAMPTON, ON, ...

The Indomo ClearPen is yet to be approved in the UK, but the founders hope for future availability ...

Backed by DST Global, Aikido Security's $60 million Series B will fund global expansion and boost its AI-powered security ...

Sharing technology without attending to the unique educational needs of students who are deaf does little to enhance the learning process for these young men and women. Therefore, using proven ...

Dec 29 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the ...

Yicai said that Novo cut Wegovy's two highest doses' list pricing by 48% to 987 yuan ($141) and 1,284 yuan per month in certain areas. The business stated the change would reduce patient costs and ...

Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the Danish drugmaker and Chinese drug suppliers. Novo did not give details ...

FRIDAY, Jan. 2, 2026 (HealthDay News) -- For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total hospital admissions, according to a ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

Novo Nordisk launched the pill version of its weight-loss drug, Wegovy, in the United States on Monday. After GLP-1 (Glucagon-Like Peptide-1) drugs like Ozempic and Wegovy took the fitness world by ...